Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stern-Wywiol Gruppe is a global, family-owned leader in the development and production of functional ingredients for food, animal nutrition, and life sciences. Headquartered in Hamburg, Germany, the group operates through 12 specialized subsidiaries, including SternVitamin, SternLife, and SternEnzym, which focus on high-growth sectors like nutraceuticals and biotechnology. The company provides comprehensive contract development and manufacturing (CDMO) services, specializing in vitamin and mineral premixes, functional bars, and protein powders. Their state-of-the-art Stern-Technology Center in Ahrensburg facilitates application-specific research across various disciplines, from flour technology to lipid chemistry. With a strong international presence and a focus on customized solutions, the group serves as a vital partner for the global food and healthcare industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stern-Wywiol Gruppe.